| Course | Title of Course | Credit | Ref. No. | Section | Day | Hour | Bldg. | Room | Instructor | Consent Required | Seats Remaining | Status |
| 100A | INTROD TOPICS PHARMACY I | 1.0 | 24815 | LEC V0A | T | 2:00P - 3:50P | KPB | 00201 | Euler,M | No | 5 | OPEN |
| Note: Consent number required at registration | ||||||||||||
| 101 | PROF SKILL DEVELOPMENT I | 2.0 | 24820 | LEC V0A | TR | 08:30A - 09:20A | KPB | 00201 | Marken,P | No | 5 | OPEN |
| 125 | MEDICAL TERMINOLOGY | 1.0 | 24832 | RSD V0A | ARR | Stoner,S | No | 0 | CLOSED | |||
| Note: Half the First Year students will enroll fall semester and the remaining First Years will enroll in winter semester. | ||||||||||||
| 151 | INTRO TO PHARMACY LAW | 1.0 | 24835 | LEC V0A | T | 11:00A - 11:50A | HH | 00301 | Brown,W | No | 1 | OPEN |
| 202 | PHARMACEUTICS I | 4.0 | LEC V0A | MWF | 11:00A - 11:50A | HH | 00301 | Neau,S | No | 0 | CLOSED | |
| Note: PHARM 202 SI meets Wed, 10:00 11:00 am in KPB 210. Second year students must successfully complete BCLS prior to enrollment in ANY third year course Note: Any student enrolling in PHARM 202 lab section (1-2) will also be enrolled in PHARM 202 A | ||||||||||||
| 202 | PHARMACEUTICS I | 4.0 | 24850 | LAB V01 | M | 2:00P - 4:50P | Neau,S | No | 0 | CLOSED | ||
| Note: PHARM 202 SI meets Wed, 10:00 11:00 am in KPB 210. Second year students must successfully complete BCLS prior to enrollment in ANY third year course Note: Lab meets at 4747 Troost building | ||||||||||||
| 202 | PHARMACEUTICS I | 4.0 | 24851 | LAB V02 | W | 2:00P - 4:50P | Neau,S | No | 0 | CLOSED | ||
| Note: PHARM 202 SI meets Wed, 10:00 11:00 am in KPB 210. Second year students must successfully complete BCLS prior to enrollment in ANY third year course Note: Lab meets at 4747 Troost Building | ||||||||||||
| 245 | TOP 200 I | 0.5 | 24860 | LEC V0A | ARR | Lea,J | No | 0 | CLOSED | |||
| Note: Half of the Third Year students will enroll during the fall semester and the remaining Third Years will enroll in the winter semester | ||||||||||||
| 307 | DISEASE PROCESSES PHARM | 3.0 | 24895 | LEC V0A | TR | 08:00A - 09:15A | KPB | 00301 | Krueger,T | No | 3 | OPEN |
| 310 | ACADEMIC SERV LEARNING I | 1.0 | 24900 | FLD V0A | ARR | Euler,M | No | 7 | OPEN | |||
| Note: ALL Third Year students MUST enroll fall semester Note: Proof of immunization and BCLS certification required in addition to prerequisited | ||||||||||||
| 310 | ACADEMIC SERV LEARNING I | 1.0 | 24901 | FLD V0B | ARR | Euler,M | No | 0 | CLOSED | |||
| Note: ALL Third Year students MUST enroll fall semester Note: Proof of immunization and BCLS certification required in addition to prerequisited | ||||||||||||
| 313 | CAREER PLANNING | 1.0 | 24912 | LEC V0A | F | 09:00A - 12:00P | KPB | 00210 | Laster,P | No | 1 | OPEN |
| Note: Pharm 313 meets only on selected Fridays | ||||||||||||
| 323 | ISLAM MODERN PRAC MED PH | 1.0 | 24913 | LEC V0A | T | 4:00P - 4:50P | KPB | 00301 | Badr,M | No | 34 | OPEN |
| 341 | MEDICINAL CHEMISTRY I | 3.0 | 24940 | LEC V0A | TR | 09:30A - 10:45A | SCB | 0C213 | Friedman,S | No | 0 | CLOSED |
| Note: Pharm 341 tests will be held outside or regular class time on Fridays from 1-2pm in KPB 201 and 301 Note: Additional recitation discussion will be held on Fri from 1-2pm in KPB 301 | ||||||||||||
| 345 | TOP 200 II | 0.5 | 24950 | RSD V0A | ARR | Lea,J | No | 7 | OPEN | |||
| 361 | PHARMACOLOGY I | 4.0 | 24969 | LEC V0A | MTWR | 1:00P - 1:50P | RH | 00104 | Igwe,O | No | 18 | OPEN |
| 377 | PRINCLPS/NUTRTN SUPPORT | 2.0 | 24975 | LEC V0A | W | 10:00A - 11:50A | KPB | 00201 | Wormington,D | No | 0 | CLOSED |
| Note: Fourth professional year students must have completed a minimum of 10.0 credit hours of professional electives prior to enrolling in final year experimental rotations. | ||||||||||||
| 389 | ADV IN DRUG THERAPY | 2.0 | 24980 | LEC V0A | MW | 1:00P - 1:50P | KPB | 00301 | Mitra,A | No | 3 | OPEN |
| 397 | HOME HEALTH CARE | 2.0 | 24985 | LEC V0A | T | 08:00A - 09:50A | KPB | 00210 | Lotspeich,D | No | 15 | OPEN |
| 404P | DRUG INFO CLERKSHIP | 4.0 | 24997 | FLD XCB | ARR | Brown,W | No | 9 | OPEN | |||
| 404P | DRUG INFO CLERKSHIP | 4.0 | 24998 | FLD V0A | ARR | Euler,M | No | 40 | OPEN | |||
| 406P | GENERAL MEDICINE I | 4.0 | 25000 | FLD V0A | ARR | Euler,M | No | 9 | OPEN | |||
| 406P | GENERL MED I | 4.0 | 50200 | FLD V0B | ARR | Brown,W | No | 10 | OPEN | |||
| 407P | GEN MED II | 6.0 | 25003 | FLD V0A | ARR | Euler,M | No | 39 | OPEN | |||
| 407P | GENERAL MEDICINE II | 6.0 | 50250 | FLD V0B | ARR | Brown,W | No | 10 | OPEN | |||
| 409P | HLTH SYSTEMS CLERKSHIP | 4.0 | 25010 | FLD V0A | ARR | Euler,M | No | 37 | OPEN | |||
| 410P | GENERAL MEDICINE III | 4.0 | 25013 | FLD V0A | ARR | Euler,M | No | 39 | OPEN | |||
| 410P | GENERAL MEDICINE III | 4.0 | 50300 | FLD V0B | ARR | Brown,W | No | 10 | OPEN | |||
| 412P | COMM PHARM PRAC CLERKSHP | 4.0 | 25020 | FLD V0A | ARR | Euler,M | No | 39 | OPEN | |||
| 418P | ELECTIVE CLERKSHIP | 4.0 | 25033 | FLD V0A | ARR | Euler,M | No | 33 | OPEN | |||
| 418P | ELECTIVE CLERKSHIP | 4.0 | 50350 | FLD V0B | ARR | Brown,W | No | 10 | OPEN | |||
| 419P | DIR INDV ROT PHM PRAC II | 4.0 | 25038 | FLD V0A | ARR | Euler,M | No | 68 | OPEN | |||
| 419P | DIR INDV ROT PHM PRAC II | 4.0 | 50400 | FLD V0B | ARR | Brown,W | No | 10 | OPEN | |||
| 420 | PHARMACOTHERAPY II | 7.0 | LEC V0A | MW | 2:00P - 5:00P | RH | 00104 | Graham,M | No | 7 | OPEN | |
| 420 | PHARMACOTHERAPY II | 7.0 | 25043 | FLD V01 | R | 1:00P - 4:00P | KPB | 00301 | Graham,M | No | 1 | OPEN |
| 420 | PHARMACOTHERAPY II | 5.0 | 50450 | FLD V0B | ARR | Brown,W | No | 10 | OPEN | |||
| 420P | DIR IND ROT PHR PRAC III | 4.0 | 25046 | FLD V0A | ARR | Euler,M | No | 9 | OPEN | |||
| 420P | DIR IND ROT PHR PRAC III | 4.0 | 50500 | FLD XCB | ARR | Brown,W | No | 10 | OPEN | |||
| 421P | DIR IND ROT PHR PRAC IV | 4.0 | 25048 | FLD V0A | ARR | Euler,M | No | 9 | OPEN | |||
| 421P | DIR IND ROT PHR PRAC IV | 4.0 | 50550 | FLD V0B | ARR | Brown,W | No | 12 | OPEN | |||
| 423P | BIOSTATISTICS FOR PHARM | 3.0 | 50600 | FLD XCB | ARR | Brown,W | No | 20 | OPEN | |||
| 424 | INTRO NAT PRODUCT THERAP | 2.0 | 25050 | LEC V0A | T | 10:00A - 11:50A | KPB | 00210 | McQueen,C | No | 3 | OPEN |
| 425P | AMBULATORY CARE CLERK II | 4.0 | 50650 | FLD XCB | ARR | Brown,W | No | 20 | OPEN | |||
| 427 | HOSPITAL PHARMACY | 2.0 | 25058 | LEC V0A | W | 08:00A - 09:50A | KPB | 00201 | Anderson,J | No | 2 | OPEN |
| 451 | PHARMACY LAW & ETHICS | 2.0 | 25065 | LEC V0A | T | 2:00P - 3:50P | KPB | 00301 | Brown,W | No | 0 | CLOSED |
| 455P | CLINICAL PHARMACOKINETIC | 4.0 | 50700 | FLD XCB | ARR | Brown,W | No | 20 | OPEN | |||
| 457P | RESEARCH METHODS | 2.0 | 50705 | LEC XCB | ARR | Brown,W | No | 20 | OPEN | |||
| 465 | ECONOMICS OF HLTH & MED | 3.0 | 25080 | LEC V0A | M | 2:00P - 4:50P | RH | 00111 | Brown,W | No | 23 | OPEN |
| 484P | PHARMACY SEMINAR | 1.0 | 25090 | FLD V0A | W | 3:00P - 5:00P | McQueen,C | Yes | 14 | OPEN | ||
| Note: Consent number required at registration. Note: Class meets at the Med School | ||||||||||||
| 485P | THERAPEUTICS III | 5.0 | 50750 | FLD XCA | ARR | Brown,W | No | 20 | OPEN | |||
| 489E | SPECIAL TOPICS PHARMACY | 1.0-5.0 | 25120 | LEC V0A | M | 3:30P - 5:20P | BLOCH | 00005 | Hewins,J | No | 1 | OPEN |
| Topic: Computers in Pharmacy | ||||||||||||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 25140 | I S V0A | ARR | Staff | Yes | 0 | CLOSED | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50801 | I S V0C | ARR | Friedman,S | Yes | 9 | OPEN | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50802 | I S V0D | ARR | Lee,C | Yes | 10 | OPEN | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50803 | I S V0E | ARR | Neau,S | Yes | 10 | OPEN | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50804 | I S V0F | ARR | Mitra,A | Yes | 10 | OPEN | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50805 | I S V0G | ARR | Johnston,T | Yes | 10 | OPEN | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50806 | I S V0H | ARR | Tombran-Tink,J | Yes | 10 | OPEN | |||
| 497A | DIR INDV STUDY PHARMACY | 1.0-4.0 | 50807 | I S V0I | ARR | Gutheil,W | Yes | 10 | OPEN | |||
| 497B | DIR INDV STDY PHRM ADMN | 1.0-4.0 | 25148 | I S V0A | ARR | Brown,W | No | 0 | CLOSED | |||
| 497B | DIR INDV STDY PHRM ADMN | 1.0-4.0 | 50851 | I S V0C | ARR | Brown,W | Yes | 10 | OPEN | |||
| 497C | DIR IND ST PHRMCEUT CHM | 1.0-4.0 | 25165 | I S V0A | ARR | Friedman,S | No | 0 | CLOSED | |||
| 497C | DIR IND ST PHRMCEUT CHM | 1.0-4.0 | 25166 | I S V0B | ARR | Resch,G | No | 9 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 25186 | I S V0A | ARR | Staff | Yes | 0 | CLOSED | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50901 | I S V0C | ARR | Piepho,R | Yes | 10 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50902 | I S V0D | ARR | Badr,M | Yes | 10 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50904 | I S V0F | ARR | Igwe,O | Yes | 10 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50905 | I S V0G | ARR | Lau,Y | Yes | 9 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50906 | I S V0H | ARR | Kearns,G | Yes | 10 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50908 | I S V0J | ARR | Scheuer,D | Yes | 7 | OPEN | |||
| 497D | DIR IND ST PHARMACOLOGY | 1.0-4.0 | 50909 | I S V0K | ARR | Wang,J | Yes | 9 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 25246 | I S V0A | ARR | Staff | Yes | 0 | CLOSED | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50950 | I S V0B | ARR | Knell,M | Yes | 9 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50951 | I S V0C | ARR | Lea,J | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50952 | I S V0D | ARR | Garvin,C | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50953 | I S V0E | ARR | Button,B | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50954 | I S V0F | ARR | Manley,H | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50955 | I S V0G | ARR | Santee,J | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50956 | I S V0H | ARR | Euler,M | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50957 | I S V0I | ARR | Norris,K | Yes | 9 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50958 | I S V0J | ARR | Lindsey,C | Yes | 8 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50959 | I S V0K | ARR | Marken,P | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50960 | I S V0L | ARR | Carroll,C | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50961 | I S V0M | ARR | Clay,P | Yes | 8 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50962 | I S V0N | ARR | Bryant,P | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50963 | I S V0O | ARR | Sommi,R | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50964 | I S V0P | ARR | Krueger,T | Yes | 10 | OPEN | |||
| 497E | DIR IND ST-CLINICAL PHAR | 1.0-4.0 | 50965 | I S V0Q | ARR | McQueen,C | Yes | 10 | OPEN | |||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51100 | I S V0B | ARR | Piepho,R | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51101 | I S V0C | ARR | Badr,M | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51102 | I S V0D | ARR | Scheuer,D | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51103 | I S V0E | ARR | Yourtee,D | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51104 | I S V0F | ARR | Igwe,O | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51105 | I S V0G | ARR | Lau,Y | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51106 | I S V0H | ARR | Ahmed,M | No | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51108 | I S V0J | ARR | Scheuer,D | Yes | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51109 | I S V0K | ARR | Wang,J | Yes | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498 | INTRO RESCH PHARMACOLOGY | 2.0 | 51110 | I S V0L | ARR | Taylor,B | Yes | 10 | OPEN | |||
| Prerequisite: Pharm 361 | ||||||||||||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51000 | I S V0B | ARR | Melethil,S | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51001 | I S V0C | ARR | Friedman,S | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51002 | I S V0D | ARR | Lee,C | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51003 | I S V0E | ARR | Neau,S | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51004 | I S V0F | ARR | Mitra,A | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51005 | I S V0G | ARR | Johnston,T | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51006 | I S V0H | ARR | Gutheil,W | No | 10 | OPEN | |||
| 498A | INTRO RESEARCH-PHARMACY | 2.0-4.0 | 51007 | I S V0I | ARR | Tombran-Tink,J | No | 10 | OPEN | |||
| 498B | INTRO RESCH PHAR ADMIN | 2.0-4.0 | 51050 | I S V0B | ARR | Gumbhir,A | No | 10 | OPEN | |||
| 498B | INTRO RESCH PHAR ADMIN | 2.0-4.0 | 51051 | I S V0C | ARR | Brown,W | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51150 | I S V0B | ARR | Lindsey,C | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51151 | I S V0C | ARR | Euler,M | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51152 | I S V0D | ARR | Dugan,J | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51153 | I S V0E | ARR | Knell,M | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51154 | I S V0F | ARR | Mangum,S | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51155 | I S V0G | ARR | Garvin,C | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51156 | I S V0H | ARR | Clay,P | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51157 | I S V0I | ARR | Manley,H | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51158 | I S V0J | ARR | Carroll,C | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51159 | I S V0K | ARR | Santee,J | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51160 | I S V0L | ARR | Marken,P | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51161 | I S V0M | ARR | Bryant,P | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51162 | I S V0N | ARR | Sommi,R | No | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51166 | I S V0O | ARR | Kraenow,K | Yes | 10 | OPEN | |||
| 498E | INTRO RES-CLINICAL PHARM | 2.0-4.0 | 51167 | I S V0Q | ARR | MCQUEEN,CYDNEY | No | 10 | OPEN | |||
| 507 | BASIC PHARMACOLOGY | 3.0 | 25590 | LEC V0A | TWR | 08:00A - 08:50A | Badr,M | No | 16 | OPEN | ||
| Note: Class meets at the Dental School, room 202 | ||||||||||||
| 519 | PHARMACOLOGY I | 4.0 | 25620 | LEC V0A | MTWR | 1:00P - 1:50P | RH | 00104 | Igwe,O | No | 20 | OPEN |
| 527 | ANAL DRUGS/TOXIC SUB I | 3.0 | 25623 | LEC V0A | ARR | Gutheil,W | No | 10 | OPEN | |||
| 550 | STABILITY OF PHARMCEUTCL | 3.0 | 25630 | LEC V0A | TR | 09:30A - 10:45A | KPB | 00201 | Johnston,T | No | 0 | CLOSED |
| 580A | SEM IN PHARMACEUTICL SCI | 1.0 | 25650 | RSD V0A | R | 4:00P - 5:00P | KPB | 00201 | Mitra,A | No | 37 | OPEN |
| 580C | SEMNR IN PHARMC/TOXICOLG | 1.0 | 25660 | RSD V0A | W | 4:00P - 5:15P | Mark,K | No | 46 | OPEN | ||
| Note: Class meets at the Med School | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 3.0 | 25730 | LEC V0A | R | 7:00P - 10:00P | KPB | 00201 | Niebergall,P | No | 13 | OPEN |
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51250 | I S V0B | ARR | Melethil,S | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51251 | I S V0C | ARR | Friedman,S | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51252 | I S V0D | ARR | Lee,C | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51253 | I S V0E | ARR | Neau,S | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51254 | I S V0F | ARR | Mitra,A | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51255 | I S V0G | ARR | Johnston,T | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51256 | I S V0H | ARR | Gutheil,W | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590A | SPECIAL TOPICS PHARMACY | 1.0-3.0 | 51257 | I S V0I | ARR | Tombran-Tink,J | No | 10 | OPEN | |||
| Topic: Experimental Design for the Pharmaceutical and Chemical Sciences | ||||||||||||
| 590BB | ST: TOXICOLOGY | 1.0-3.0 | 25750 | I S V0A | ARR | Staff | No | 0 | CLOSED | |||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 25760 | I S V0A | ARR | Lau,Y | No | 15 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51350 | I S V0B | ARR | Ahmed,M | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51351 | I S V0C | ARR | Piepho,R | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51352 | I S V0D | ARR | Badr,M | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51353 | I S V0E | ARR | Igwe,O | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51354 | I S V0F | ARR | Taylor,B | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51358 | I S V0J | ARR | Scheuer,D | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51359 | I S V0K | ARR | Wang,J | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 590C | SPEC TOP PHARMACOLOGY | 1.0-3.0 | 51360 | I S V0L | ARR | Taylor,B | No | 10 | OPEN | |||
| Topic: Advanced Neuropharmacology | ||||||||||||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25800 | I S V0A | ARR | Lee,C | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25820 | I S V0C | ARR | Friedman,S | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25830 | I S V0D | ARR | Tombran-Tink,J | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25840 | I S V0E | ARR | Mitra,A | No | 13 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25850 | I S V0F | ARR | Neau,S | No | 13 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25851 | I S V0G | ARR | Johnston,T | No | 15 | OPEN | |||
| 599A | RSCH & THESIS PHARM | 1.0-9.0 | 25852 | I S V0H | ARR | Gutheil,W | No | 14 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25890 | I S V0A | ARR | Lau,Y | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25900 | I S V0B | ARR | Kearns,G | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25910 | I S V0C | ARR | Piepho,R | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25920 | I S V0D | ARR | Badr,M | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25923 | I S V0E | ARR | Igwe,O | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25924 | I S V0F | ARR | Wang,J | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25926 | I S V0H | ARR | Mark,K | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25927 | I S V0I | ARR | Scheuer,D | No | 10 | OPEN | |||
| 599C | RSCH & THES PHARMACOL | 1.0-9.0 | 25928 | I S V0J | ARR | Wang,Q | No | 10 | OPEN | |||
| 615 | METH IN PHARM&TOXICOLOGY | 3.0 | 25930 | I S V0A | ARR | Scheuer,D | No | 7 | OPEN | |||
| Note: Contact instructor to schedule rotations | ||||||||||||
| 645 | CANCER BIOTECHNOLOGY I | 3.0 | 25933 | LEC V0A | W | 7:00P - 10:00P | KPB | 00201 | Tombran-Tink,J | Yes | 3 | OPEN |
| Prerequisite: Cell Biology Note: Consent number required at registration | ||||||||||||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25935 | I S V0A | A | Tombran-Tink,J | No | 15 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25950 | I S V0C | ARR | Lee,C | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25960 | I S V0D | ARR | Friedman,S | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25970 | I S V0E | ARR | Neau,S | No | 9 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25980 | I S V0F | ARR | Mitra,A | No | 10 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25981 | I S V0G | ARR | Johnston,T | No | 9 | OPEN | |||
| 690A | SPEC TOPICS PHARM | 1.0-3.0 | 25982 | I S V0H | ARR | Gutheil,W | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 26020 | I S V0A | ARR | Staff | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 26030 | I S V0B | ARR | Kearns,G | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 26040 | I S V0C | ARR | Piepho,R | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 26050 | I S V0D | ARR | Badr,M | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 26055 | I S V0E | ARR | Igwe,O | No | 10 | OPEN | |||
| 690C | SPEC TPS PHARMACOLOGY | 1.0-3.0 | 26056 | I S V0F | ARR | Lau,Y | No | 10 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26060 | I S V0A | ARR | Tombran-Tink,J | No | 13 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26090 | I S V0C | ARR | Lee,C | No | 15 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26100 | I S V0D | ARR | Neau,S | No | 7 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26110 | I S V0E | ARR | Mitra,A | No | 0 | CLOSED | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26111 | I S V0F | ARR | Johnston,T | No | 10 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26112 | I S V0G | ARR | Friedman,S | No | 13 | OPEN | |||
| 699A | RESCH&DISERTATN-PHARMACY | 1.0-16.0 | 26113 | I S V0H | ARR | Gutheil,W | No | 14 | OPEN | |||
| 699B | RES & DISSER PHARM CHEM | 1.0-16.0 | 26140 | I S V0A | ARR | Friedman,S | No | 10 | OPEN | |||
| 699BB | RSRCH & DISS TOXICOLOGY | 1.0-16.0 | 26150 | I S V0A | ARR | Staff | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26160 | I S V0A | ARR | Kearns,G | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26165 | I S V0B | ARR | Piepho,R | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26170 | I S V0C | ARR | Badr,M | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26171 | I S V0D | ARR | Igwe,O | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26172 | I S V0E | ARR | Lau,Y | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26173 | I S V0F | ARR | Wang,J | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26174 | I S V0G | ARR | Mark,K | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26175 | I S V0H | ARR | Scheuer,D | No | 10 | OPEN | |||
| 699C | RES & DISSER PHARMACOL | 1.0-16.0 | 26177 | I S V0J | ARR | Wang,Q | No | 9 | OPEN | |||